These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1378308)

  • 1. Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining.
    Hodsman AB; Steer BM
    J Am Soc Nephrol; 1992 Feb; 2(8):1318-27. PubMed ID: 1378308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staining of bone for aluminum: use of acid solochrome azurine.
    Kaye M; Hodsman AB; Malynowsky L
    Kidney Int; 1990 Apr; 37(4):1142-7. PubMed ID: 1692893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum deposition in the bone of patients with chronic renal failure--detection of aluminum accumulation without signs of aluminum toxicity in bone using acid solochrome azurine.
    Rüster M; Abendroth K; Lehmann G; Stein G
    Clin Nephrol; 2002 Oct; 58(4):305-12. PubMed ID: 12400847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of subtle aluminum-related renal osteodystrophy.
    Romanski SA; McCarthy JT; Kluge K; Fitzpatrick LA
    Mayo Clin Proc; 1993 May; 68(5):419-26. PubMed ID: 7683072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemical staining of bone aluminum: comparison of aluminon and acid solochrome azurine and their correlation with bone aluminum content.
    dos Reis LM; Tzanno-Martins C; Jorgetti V
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(4):171-4. PubMed ID: 9567366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staining of bone aluminium: comparison between aluminon and solochrome azurine and their correlation with bone aluminium content.
    Fernández-Martín JL; Menéndez P; Acuña G; Canteros A; Gómez C; Cannata JB
    Nephrol Dial Transplant; 1996; 11 Suppl 3():80-5. PubMed ID: 8840315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal osteodystrophy in asymptomatic hemodialysis patients: evidence of a sex-dependent distribution and predictive value of serum aluminum measurements.
    von Herrath D; Asmus G; Pauls A; Delling G; Schaefer K
    Am J Kidney Dis; 1986 Dec; 8(6):430-5. PubMed ID: 3812472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal osteodystrophy in pre-dialysis patients: ethnic difference?
    Shin SK; Kim DH; Kim HS; Shin KT; Ma KA; Kim SJ; Kwak YS; Ha SK; Sherrard DJ
    Perit Dial Int; 1999; 19 Suppl 2():S402-7. PubMed ID: 10406554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of bone disorders in chronic renal failure and dialyzed patients.
    Tzamaloukas AH
    Med Clin North Am; 1990 Jul; 74(4):961-74. PubMed ID: 2195265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal osteodystrophy.
    Klein KL; Maxwell MH
    Orthop Clin North Am; 1984 Oct; 15(4):687-95. PubMed ID: 6493735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of aluminium in iliac bone: correlation between aluminon and solochrome azurine staining techniques with data on flameless absorption spectrophotometry.
    Ellis HA; Pang MM; Mawhinney WH; Skillen AW
    J Clin Pathol; 1988 Nov; 41(11):1171-5. PubMed ID: 2463269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
    Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
    J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism].
    de Vernejoul MC
    Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.
    Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG
    Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum associated bone disease: clinico-pathologic correlation.
    Ihle B; Buchanan M; Stevens B; Marshal A; Plomley R; d'Apice A; Kincaid-Smith P
    Am J Kidney Dis; 1982 Sep; 2(2):255-63. PubMed ID: 7124722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.